Press Releases TELA Bio, Inc.

Equities

TELA

US8723811084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
5.53 ^USD	-1.60%		-5.47%	-16.47%

May. 20	TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer	CI
May. 10	Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TELA Bio Appoints Greg Firestone as Chief Commercial Officer	May. 20	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 10	GL
TELA Bio Reports First Quarter 2024 Financial Results	May. 09	GL
Morgans rates ARX as Add	Apr. 30	AQ
TELA Bio to Announce First Quarter 2024 Financial Results	Apr. 25	GL
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	Apr. 16	AQ
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures	Apr. 15	GL
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy	Apr. 08	GL
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results	Mar. 21	GL
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery	Mar. 21	GL
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing	Mar. 20	AQ
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX	Mar. 20	GL
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	Feb. 29	GL
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results	Feb. 29	AQ
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 23	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 19	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 15	GL
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 15	AQ
TELA Bio to Take Part in Connecting the Dots	Dec. 05	GL
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference	Nov. 16	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases TELA Bio, Inc.

Equities

TELA

US8723811084

Press Releases

Filters